We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.3B
AUM Growth
+$1.54B
(+10%)
Cap. Flow
+$794M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
1,104
New
170
Increased
359
Reduced
380
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$274M |
| 2 |
General Motors
GM
|
+$175M |
| 3 |
Cigna
CI
|
+$139M |
| 4 |
Ford
F
|
+$133M |
| 5 |
Adobe
ADBE
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$193M |
| 2 |
Tesla
TSLA
|
+$181M |
| 3 |
Palo Alto Networks
PANW
|
+$164M |
| 4 |
Microsoft
MSFT
|
+$98.7M |
| 5 |
Cardinal Health
CAH
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.57% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Financials | 12.35% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Fate Therapeutics
FATE
$275M
| $7.66M | 0.05% |
+1,343,629
| New | +$8.11M |
|
327
Vicor
VICR
$8.33B
| $7.6M | 0.05% |
161,885
+59,177
| +58% | +$3.28M |
|
328
ConocoPhillips
COP
$144B
| $7.57M | 0.05% |
76,321
+59,450
| +352% | +$6.51M |
|
329
Encore Capital Group
ECPG
$2.01B
| $7.5M | 0.05% |
148,595
+59,732
| +67% | +$3.12M |
|
330
Covenant Logistics
CVLG
$1.04B
| $7.49M | 0.05% |
423,022
-46,456
| -10% | -$804K |
|
331
Pulmonx
LUNG
$52.8M
| $7.3M | 0.04% |
652,609
+351,526
| +117% | +$3.47M |
|
332
ProPetro Holding
PUMP
$1.25B
| $7.26M | 0.04% |
1,009,537
+27,244
| +3% | +$247K |
|
333
Manitowoc
MTW
$491M
| $7.24M | 0.04% |
423,500
-14,994
| -3% | -$225K |
|
334
Alignment Healthcare
ALHC
$3.78B
| $7.19M | 0.04% |
1,131,029
+32,541
| +3% | +$310K |
|
335
Southern Company
SO
$108B
| $7.19M | 0.04% |
103,379
+98,885
| +2,200% | +$6.66M |
|
336
Inspire Medical Systems
INSP
$1.47B
| $7.16M | 0.04% |
30,608
-45,330
| -60% | -$11.5M |
|
337
Paysafe
PSFE
$443M
| $7.13M | 0.04% |
413,085
+6,473
| +2% | +$126K |
|
338
CoreCivic
CXW
$2.94B
| $7.02M | 0.04% |
762,647
-389,494
| -34% | -$4M |
|
|
ITOS
339
DELISTED
iTeos Therapeutics
ITOS
| $7.01M | 0.04% |
514,925
+11,395
| +2% | +$204K |
|
340
Universal Insurance Holdings
UVE
$1.26B
| $6.9M | 0.04% |
378,792
+15,709
| +4% | +$232K |
|
|
NSTG
341
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.88M | 0.04% |
695,342
+218,791
| +46% | +$2.17M |
|
342
Healthpeak Properties
DOC
$15.5B
| $6.87M | 0.04% |
312,689
-34,928
| -10% | -$866K |
|
|
MRTX
343
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.87M | 0.04% |
184,716
+142,694
| +340% | +$6.42M |
|
344
Sterling Infrastructure
STRL
$15.2B
| $6.85M | 0.04% |
180,876
+163,164
| +921% | +$5.96M |
|
345
Edgewell Personal Care
EPC
$1.3B
| $6.76M | 0.04% |
159,442
| – | – |
|
346
Medifast
MED
$107M
| $6.61M | 0.04% |
63,787
+4,539
| +8% | +$503K |
|
347
Benchmark Electronics
BHE
$2.66B
| $6.54M | 0.04% |
276,146
+4,129
| +2% | +$105K |
|
348
GoodRx Holdings
GDRX
$1.09B
| $6.49M | 0.04% |
1,038,164
-96,446
| -9% | -$538K |
|
349
Domo
DOMO
$171M
| $6.44M | 0.04% |
453,988
+67,982
| +18% | +$957K |
|
350
Clearwater Paper
CLW
$348M
| $6.44M | 0.04% |
192,568
-4,125
| -2% | -$149K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2023 Portfolio in Review
As of Q1 2023, Jacobs Levy Equity Management held 1,104 positions worth $16.3B, up 10% from $14.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management deployed $794M of net new capital in Q1 2023, opening 170 new positions and adding to 359 existing holdings. Its largest new stake was Cigna: 475,901 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $193M trimmed.
- Jacobs Levy Equity Management's largest Q1 2023 buy was Cigna: 475,901 shares worth $122M.
- Jacobs Levy Equity Management added most to Apple in Q1 2023, an estimated $274M increase.
- Jacobs Levy Equity Management's biggest Q1 2023 reduction was Humana, cutting an estimated $193M.
- Jacobs Levy Equity Management fully exited PayPal in Q1 2023, selling an estimated $66.4M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $16.3B portfolio in Q1 2023.
- Jacobs Levy Equity Management opened 170 new positions and closed 160 in Q1 2023.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $16.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.